| 000 | 02350 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250515201648.0 | ||
| 264 | 0 | _c20100305 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1520-6777 | ||
| 024 | 7 |
_a10.1002/nau.20746 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYokoyama, Osamu | |
| 245 | 0 | 0 |
_aPharmacological and genetic analysis of mechanisms underlying detrusor overactivity in rats. _h[electronic resource] |
| 260 |
_bNeurourology and urodynamics _c2010 |
||
| 300 |
_a107-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdrenergic alpha-1 Receptor Antagonists |
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aAfferent Pathways _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzhydryl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCerebral Infarction _xcomplications |
| 650 | 0 | 4 |
_aCresols _xpharmacology |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xmetabolism |
| 650 | 0 | 4 |
_aDinoprostone _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEarly Growth Response Protein 1 _xmetabolism |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aMuscarinic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aNerve Fibers, Unmyelinated _xdrug effects |
| 650 | 0 | 4 |
_aNeuronal Plasticity _xdrug effects |
| 650 | 0 | 4 |
_aPhenylpropanolamine _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, AMPA _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Prostaglandin E _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReceptors, Prostaglandin E, EP1 Subtype |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 | _aTamsulosin |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTolterodine Tartrate |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aUrinary Bladder _xdrug effects |
| 650 | 0 | 4 |
_aUrinary Bladder, Overactive _xdrug therapy |
| 773 | 0 |
_tNeurourology and urodynamics _gvol. 29 _gno. 1 _gp. 107-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/nau.20746 _zAvailable from publisher's website |
| 999 |
_c19405800 _d19405800 |
||